The office of Novartis near Basel, Switzerland. Reuters
Swiss drugmaker Novartis on won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
Novartis plans to answer a US senator who demanded details about data manipulation related to its gene therapy Zolgensma, amid scrutiny of the Swiss drugmaker’s decision to delay informing regulators
Mubadala Investment Company, through its healthcare arm, has signed a memorandum of understanding (MoU) with Nirvana Travel and Tourism to formalise their intention to collaborate on projects that will support a key Abu Dhabi Vision 2030
Etihad Credit Insurance (ECI), the UAE Federal credit insurance company, has signed a Memorandum of Understanding (MoU) with Mohammed Bin Rashid School of Government (MBRSG) to jointly build a framework of excellence
German automaker Daimler plans to build Mercedes Benz branded heavy trucks in China by revamping truck plants owned by its local joint venture (JV), according to a document seen by Reuters and two sources familiar with the matter.
The Dubai International Financial Centre (DIFC) Courts on Sunday released its figures for the first half of 2019, with a total volume of 463 cases across all divisions for the first six months of 2019, a 25 per cent increase from the first half of 2018.